The effectiveness of 2-PAM and TMB-4 as adjuncts to atropine therapy in dogs exposed to Sarin vapor by inhalation.
D000818:Animals; D001285:Atropine / Q000494:pharmacology*; D002800:Cholinesterase Inhibitors; D004285:Dogs; D006898:Hydroxylamines / Q000494:pharmacology*; D010710:Phosphates / Q000633:toxicity*; D011220:Pralidoxime Compounds; D011725:Pyridines / Q000494:pharmacology*; D012524:Sarin; D014289:Trimedoxime
D002800:Cholinesterase Inhibitors; D006898:Hydroxylamines; D010710:Phosphates; D011220:Pralidoxime Compounds; D011725:Pyridines; D014289:Trimedoxime; D001285:Atropine; D012524:Sarin; C028797:pralidoxime
ATROPINE/pharmacology; CHOLINESTERASE/antagonists; HYDROXYLAMINES/pharmacology; PHOSPHATES/toxicology; PYRIDINES/pharmacology